nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—SLCO1B3—Methotrexate—multiple sclerosis	0.109	0.171	CbGbCtD
Pioglitazone—CYP2D6—Fingolimod—multiple sclerosis	0.0875	0.137	CbGbCtD
Pioglitazone—SLCO1B1—Methotrexate—multiple sclerosis	0.0635	0.0996	CbGbCtD
Pioglitazone—CYP3A4—Fingolimod—multiple sclerosis	0.0557	0.0873	CbGbCtD
Pioglitazone—CYP2C19—Prednisone—multiple sclerosis	0.045	0.0705	CbGbCtD
Pioglitazone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0359	0.0562	CbGbCtD
Pioglitazone—CYP2C8—Dexamethasone—multiple sclerosis	0.0334	0.0524	CbGbCtD
Pioglitazone—CYP2C19—Dexamethasone—multiple sclerosis	0.0281	0.044	CbGbCtD
Pioglitazone—CYP3A4—Triamcinolone—multiple sclerosis	0.0272	0.0426	CbGbCtD
Pioglitazone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0262	0.041	CbGbCtD
Pioglitazone—CYP2C9—Dexamethasone—multiple sclerosis	0.0233	0.0366	CbGbCtD
Pioglitazone—CYP3A4—Betamethasone—multiple sclerosis	0.0233	0.0366	CbGbCtD
Pioglitazone—CYP3A4—Prednisolone—multiple sclerosis	0.023	0.0361	CbGbCtD
Pioglitazone—CYP3A4—Prednisone—multiple sclerosis	0.0217	0.0341	CbGbCtD
Pioglitazone—CYP2D6—Dexamethasone—multiple sclerosis	0.0213	0.0335	CbGbCtD
Pioglitazone—CYP3A4—Dexamethasone—multiple sclerosis	0.0136	0.0213	CbGbCtD
Pioglitazone—Rosiglitazone—ALB—multiple sclerosis	0.000721	1	CrCbGaD
Pioglitazone—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00049	0.00165	CcSEcCtD
Pioglitazone—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000489	0.00165	CcSEcCtD
Pioglitazone—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000481	0.00162	CcSEcCtD
Pioglitazone—Anaemia—Mitoxantrone—multiple sclerosis	0.000479	0.00161	CcSEcCtD
Pioglitazone—Sweating—Methylprednisolone—multiple sclerosis	0.000478	0.00161	CcSEcCtD
Pioglitazone—Hepatic failure—Methotrexate—multiple sclerosis	0.000477	0.00161	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000476	0.00161	CcSEcCtD
Pioglitazone—Hypersensitivity—Cladribine—multiple sclerosis	0.000474	0.0016	CcSEcCtD
Pioglitazone—Visual impairment—Prednisolone—multiple sclerosis	0.00047	0.00159	CcSEcCtD
Pioglitazone—Malaise—Mitoxantrone—multiple sclerosis	0.000467	0.00158	CcSEcCtD
Pioglitazone—Weight increased—Betamethasone—multiple sclerosis	0.000463	0.00156	CcSEcCtD
Pioglitazone—Weight increased—Dexamethasone—multiple sclerosis	0.000463	0.00156	CcSEcCtD
Pioglitazone—Asthenia—Cladribine—multiple sclerosis	0.000461	0.00156	CcSEcCtD
Pioglitazone—Weight decreased—Betamethasone—multiple sclerosis	0.00046	0.00155	CcSEcCtD
Pioglitazone—Weight decreased—Dexamethasone—multiple sclerosis	0.00046	0.00155	CcSEcCtD
Pioglitazone—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000459	0.00155	CcSEcCtD
Pioglitazone—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000459	0.00155	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000452	0.00153	CcSEcCtD
Pioglitazone—Visual disturbance—Methotrexate—multiple sclerosis	0.000452	0.00153	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000451	0.00152	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000447	0.00151	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000447	0.00151	CcSEcCtD
Pioglitazone—Hypertension—Mitoxantrone—multiple sclerosis	0.000447	0.00151	CcSEcCtD
Pioglitazone—Pharyngitis—Triamcinolone—multiple sclerosis	0.000446	0.0015	CcSEcCtD
Pioglitazone—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000445	0.0015	CcSEcCtD
Pioglitazone—Myocardial infarction—Betamethasone—multiple sclerosis	0.000445	0.0015	CcSEcCtD
Pioglitazone—Arthralgia—Mitoxantrone—multiple sclerosis	0.000441	0.00149	CcSEcCtD
Pioglitazone—Chest pain—Mitoxantrone—multiple sclerosis	0.000441	0.00149	CcSEcCtD
Pioglitazone—Myalgia—Mitoxantrone—multiple sclerosis	0.000441	0.00149	CcSEcCtD
Pioglitazone—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.00044	0.00148	CcSEcCtD
Pioglitazone—Diarrhoea—Cladribine—multiple sclerosis	0.00044	0.00148	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.000437	0.00148	CcSEcCtD
Pioglitazone—Discomfort—Mitoxantrone—multiple sclerosis	0.000436	0.00147	CcSEcCtD
Pioglitazone—Visual impairment—Methylprednisolone—multiple sclerosis	0.000432	0.00146	CcSEcCtD
Pioglitazone—Feeling abnormal—Azathioprine—multiple sclerosis	0.000431	0.00145	CcSEcCtD
Pioglitazone—Dizziness—Cladribine—multiple sclerosis	0.000425	0.00143	CcSEcCtD
Pioglitazone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000423	0.00143	CcSEcCtD
Pioglitazone—Oedema—Mitoxantrone—multiple sclerosis	0.000423	0.00143	CcSEcCtD
Pioglitazone—Infection—Mitoxantrone—multiple sclerosis	0.00042	0.00142	CcSEcCtD
Pioglitazone—Eye disorder—Methylprednisolone—multiple sclerosis	0.000419	0.00141	CcSEcCtD
Pioglitazone—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000416	0.0014	CcSEcCtD
Pioglitazone—Skin disorder—Mitoxantrone—multiple sclerosis	0.000411	0.00139	CcSEcCtD
Pioglitazone—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00041	0.0063	CbGpPWpGaD
Pioglitazone—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000409	0.00138	CcSEcCtD
Pioglitazone—Erectile dysfunction—Prednisone—multiple sclerosis	0.000408	0.00138	CcSEcCtD
Pioglitazone—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000405	0.00136	CcSEcCtD
Pioglitazone—PPARG—Developmental Biology—CD24—multiple sclerosis	0.000404	0.0062	CbGpPWpGaD
Pioglitazone—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000404	0.00136	CcSEcCtD
Pioglitazone—Weight increased—Prednisone—multiple sclerosis	0.000403	0.00136	CcSEcCtD
Pioglitazone—Headache—Cladribine—multiple sclerosis	0.000403	0.00136	CcSEcCtD
Pioglitazone—Weight decreased—Prednisone—multiple sclerosis	0.000401	0.00135	CcSEcCtD
Pioglitazone—Hyperglycaemia—Prednisone—multiple sclerosis	0.0004	0.00135	CcSEcCtD
Pioglitazone—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000396	0.00133	CcSEcCtD
Pioglitazone—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000394	0.00133	CcSEcCtD
Pioglitazone—Visual impairment—Dexamethasone—multiple sclerosis	0.000393	0.00132	CcSEcCtD
Pioglitazone—Visual impairment—Betamethasone—multiple sclerosis	0.000393	0.00132	CcSEcCtD
Pioglitazone—Malnutrition—Methylprednisolone—multiple sclerosis	0.00039	0.00132	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00039	0.00131	CcSEcCtD
Pioglitazone—Angioedema—Prednisolone—multiple sclerosis	0.000388	0.00131	CcSEcCtD
Pioglitazone—Myocardial infarction—Prednisone—multiple sclerosis	0.000387	0.00131	CcSEcCtD
Pioglitazone—Breast disorder—Methotrexate—multiple sclerosis	0.000387	0.00131	CcSEcCtD
Pioglitazone—Hypersensitivity—Azathioprine—multiple sclerosis	0.000385	0.0013	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000385	0.0013	CcSEcCtD
Pioglitazone—Malaise—Prednisolone—multiple sclerosis	0.000383	0.00129	CcSEcCtD
Pioglitazone—PPARG—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000383	0.00588	CbGpPWpGaD
Pioglitazone—Vertigo—Prednisolone—multiple sclerosis	0.000382	0.00129	CcSEcCtD
Pioglitazone—Eye disorder—Dexamethasone—multiple sclerosis	0.000381	0.00128	CcSEcCtD
Pioglitazone—Eye disorder—Betamethasone—multiple sclerosis	0.000381	0.00128	CcSEcCtD
Pioglitazone—Back pain—Triamcinolone—multiple sclerosis	0.000378	0.00128	CcSEcCtD
Pioglitazone—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	0.000378	0.00581	CbGpPWpGaD
Pioglitazone—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	0.000378	0.00581	CbGpPWpGaD
Pioglitazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000377	0.0058	CbGpPWpGaD
Pioglitazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000377	0.0058	CbGpPWpGaD
Pioglitazone—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000377	0.00127	CcSEcCtD
Pioglitazone—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000374	0.00575	CbGpPWpGaD
Pioglitazone—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000374	0.00575	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00037	0.00569	CbGpPWpGaD
Pioglitazone—Hypertension—Prednisolone—multiple sclerosis	0.000367	0.00124	CcSEcCtD
Pioglitazone—Fatigue—Mitoxantrone—multiple sclerosis	0.000364	0.00123	CcSEcCtD
Pioglitazone—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000363	0.00122	CcSEcCtD
Pioglitazone—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000362	0.00122	CcSEcCtD
Pioglitazone—Diarrhoea—Azathioprine—multiple sclerosis	0.000358	0.00121	CcSEcCtD
Pioglitazone—Discomfort—Prednisolone—multiple sclerosis	0.000357	0.00121	CcSEcCtD
Pioglitazone—Angioedema—Triamcinolone—multiple sclerosis	0.000357	0.0012	CcSEcCtD
Pioglitazone—Angioedema—Methylprednisolone—multiple sclerosis	0.000356	0.0012	CcSEcCtD
Pioglitazone—Malaise—Triamcinolone—multiple sclerosis	0.000352	0.00119	CcSEcCtD
Pioglitazone—Malaise—Methylprednisolone—multiple sclerosis	0.000352	0.00119	CcSEcCtD
Pioglitazone—Vertigo—Triamcinolone—multiple sclerosis	0.000351	0.00118	CcSEcCtD
Pioglitazone—Vertigo—Methylprednisolone—multiple sclerosis	0.00035	0.00118	CcSEcCtD
Pioglitazone—Connective tissue disorder—Prednisone—multiple sclerosis	0.000349	0.00118	CcSEcCtD
Pioglitazone—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000348	0.00118	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000347	0.00117	CcSEcCtD
Pioglitazone—Oedema—Prednisolone—multiple sclerosis	0.000347	0.00117	CcSEcCtD
Pioglitazone—Dizziness—Azathioprine—multiple sclerosis	0.000346	0.00117	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000344	0.00116	CcSEcCtD
Pioglitazone—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000341	0.00115	CcSEcCtD
Pioglitazone—PPARG—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	0.000339	0.0052	CbGpPWpGaD
Pioglitazone—Hypertension—Triamcinolone—multiple sclerosis	0.000337	0.00114	CcSEcCtD
Pioglitazone—Hypertension—Methylprednisolone—multiple sclerosis	0.000337	0.00114	CcSEcCtD
Pioglitazone—Urticaria—Mitoxantrone—multiple sclerosis	0.000336	0.00113	CcSEcCtD
Pioglitazone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000335	0.00113	CcSEcCtD
Pioglitazone—Myalgia—Triamcinolone—multiple sclerosis	0.000333	0.00112	CcSEcCtD
Pioglitazone—Myalgia—Methylprednisolone—multiple sclerosis	0.000332	0.00112	CcSEcCtD
Pioglitazone—Arthralgia—Methylprednisolone—multiple sclerosis	0.000332	0.00112	CcSEcCtD
Pioglitazone—Eye disorder—Prednisone—multiple sclerosis	0.000332	0.00112	CcSEcCtD
Pioglitazone—Infestation NOS—Methotrexate—multiple sclerosis	0.00033	0.00111	CcSEcCtD
Pioglitazone—Infestation—Methotrexate—multiple sclerosis	0.00033	0.00111	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00033	0.00111	CcSEcCtD
Pioglitazone—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000329	0.00111	CcSEcCtD
Pioglitazone—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000329	0.00111	CcSEcCtD
Pioglitazone—Discomfort—Triamcinolone—multiple sclerosis	0.000329	0.00111	CcSEcCtD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000328	0.00504	CbGpPWpGaD
Pioglitazone—Discomfort—Methylprednisolone—multiple sclerosis	0.000328	0.00111	CcSEcCtD
Pioglitazone—Headache—Azathioprine—multiple sclerosis	0.000328	0.00111	CcSEcCtD
Pioglitazone—Angioedema—Betamethasone—multiple sclerosis	0.000324	0.00109	CcSEcCtD
Pioglitazone—Angioedema—Dexamethasone—multiple sclerosis	0.000324	0.00109	CcSEcCtD
Pioglitazone—Immune system disorder—Prednisone—multiple sclerosis	0.00032	0.00108	CcSEcCtD
Pioglitazone—Malaise—Dexamethasone—multiple sclerosis	0.00032	0.00108	CcSEcCtD
Pioglitazone—Malaise—Betamethasone—multiple sclerosis	0.00032	0.00108	CcSEcCtD
Pioglitazone—Oedema—Triamcinolone—multiple sclerosis	0.000319	0.00108	CcSEcCtD
Pioglitazone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000319	0.00108	CcSEcCtD
Pioglitazone—Vertigo—Betamethasone—multiple sclerosis	0.000319	0.00107	CcSEcCtD
Pioglitazone—Vertigo—Dexamethasone—multiple sclerosis	0.000319	0.00107	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000318	0.00107	CcSEcCtD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—multiple sclerosis	0.000317	0.00487	CbGpPWpGaD
Pioglitazone—Infection—Triamcinolone—multiple sclerosis	0.000317	0.00107	CcSEcCtD
Pioglitazone—Sweating—Methotrexate—multiple sclerosis	0.000317	0.00107	CcSEcCtD
Pioglitazone—Infection—Methylprednisolone—multiple sclerosis	0.000316	0.00107	CcSEcCtD
Pioglitazone—Haematuria—Methotrexate—multiple sclerosis	0.000315	0.00106	CcSEcCtD
Pioglitazone—Insomnia—Prednisolone—multiple sclerosis	0.000314	0.00106	CcSEcCtD
Pioglitazone—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000312	0.00105	CcSEcCtD
Pioglitazone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000311	0.00105	CcSEcCtD
Pioglitazone—Skin disorder—Methylprednisolone—multiple sclerosis	0.000309	0.00104	CcSEcCtD
Pioglitazone—Malnutrition—Prednisone—multiple sclerosis	0.000309	0.00104	CcSEcCtD
Pioglitazone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000308	0.00104	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000308	0.00104	CcSEcCtD
Pioglitazone—Hypertension—Dexamethasone—multiple sclerosis	0.000306	0.00103	CcSEcCtD
Pioglitazone—Hypertension—Betamethasone—multiple sclerosis	0.000306	0.00103	CcSEcCtD
Pioglitazone—SLCO1B1—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000305	0.00468	CbGpPWpGaD
Pioglitazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000304	0.00467	CbGpPWpGaD
Pioglitazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000304	0.00467	CbGpPWpGaD
Pioglitazone—Asthenia—Mitoxantrone—multiple sclerosis	0.000303	0.00102	CcSEcCtD
Pioglitazone—Myalgia—Betamethasone—multiple sclerosis	0.000302	0.00102	CcSEcCtD
Pioglitazone—Myalgia—Dexamethasone—multiple sclerosis	0.000302	0.00102	CcSEcCtD
Pioglitazone—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.0003	0.00461	CbGpPWpGaD
Pioglitazone—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.0003	0.00461	CbGpPWpGaD
Pioglitazone—Discomfort—Betamethasone—multiple sclerosis	0.000298	0.00101	CcSEcCtD
Pioglitazone—Discomfort—Dexamethasone—multiple sclerosis	0.000298	0.00101	CcSEcCtD
Pioglitazone—Hepatitis—Methotrexate—multiple sclerosis	0.000296	0.001	CcSEcCtD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—multiple sclerosis	0.000296	0.00455	CbGpPWpGaD
Pioglitazone—Pharyngitis—Methotrexate—multiple sclerosis	0.000294	0.000993	CcSEcCtD
Pioglitazone—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000293	0.000988	CcSEcCtD
Pioglitazone—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000292	0.00448	CbGpPWpGaD
Pioglitazone—Urethral disorder—Methotrexate—multiple sclerosis	0.000291	0.00098	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000291	0.00098	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00029	0.000978	CcSEcCtD
Pioglitazone—Oedema—Dexamethasone—multiple sclerosis	0.000289	0.000976	CcSEcCtD
Pioglitazone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000289	0.000976	CcSEcCtD
Pioglitazone—Oedema—Betamethasone—multiple sclerosis	0.000289	0.000976	CcSEcCtD
Pioglitazone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000289	0.000976	CcSEcCtD
Pioglitazone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000289	0.000976	CcSEcCtD
Pioglitazone—Insomnia—Triamcinolone—multiple sclerosis	0.000288	0.000973	CcSEcCtD
Pioglitazone—Insomnia—Methylprednisolone—multiple sclerosis	0.000288	0.000971	CcSEcCtD
Pioglitazone—Infection—Betamethasone—multiple sclerosis	0.000288	0.00097	CcSEcCtD
Pioglitazone—Infection—Dexamethasone—multiple sclerosis	0.000288	0.00097	CcSEcCtD
Pioglitazone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000287	0.000967	CcSEcCtD
Pioglitazone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000286	0.000964	CcSEcCtD
Pioglitazone—Visual impairment—Methotrexate—multiple sclerosis	0.000286	0.000964	CcSEcCtD
Pioglitazone—Anaemia—Prednisone—multiple sclerosis	0.000285	0.000963	CcSEcCtD
Pioglitazone—Dyspnoea—Triamcinolone—multiple sclerosis	0.000284	0.000959	CcSEcCtD
Pioglitazone—Nervous system disorder—Betamethasone—multiple sclerosis	0.000284	0.000957	CcSEcCtD
Pioglitazone—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000284	0.000957	CcSEcCtD
Pioglitazone—Angioedema—Prednisone—multiple sclerosis	0.000282	0.000952	CcSEcCtD
Pioglitazone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00028	0.000944	CcSEcCtD
Pioglitazone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00028	0.000944	CcSEcCtD
Pioglitazone—Malaise—Prednisone—multiple sclerosis	0.000278	0.000939	CcSEcCtD
Pioglitazone—Vertigo—Prednisone—multiple sclerosis	0.000277	0.000936	CcSEcCtD
Pioglitazone—Eye disorder—Methotrexate—multiple sclerosis	0.000277	0.000935	CcSEcCtD
Pioglitazone—Urticaria—Prednisolone—multiple sclerosis	0.000276	0.000929	CcSEcCtD
Pioglitazone—Cardiac disorder—Methotrexate—multiple sclerosis	0.000275	0.000928	CcSEcCtD
Pioglitazone—Fatigue—Triamcinolone—multiple sclerosis	0.000275	0.000928	CcSEcCtD
Pioglitazone—Fatigue—Methylprednisolone—multiple sclerosis	0.000274	0.000926	CcSEcCtD
Pioglitazone—PPARG—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	0.000273	0.0042	CbGpPWpGaD
Pioglitazone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000273	0.00419	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.000271	0.00417	CbGpPWpGaD
Pioglitazone—Immune system disorder—Methotrexate—multiple sclerosis	0.000268	0.000903	CcSEcCtD
Pioglitazone—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000267	0.000901	CcSEcCtD
Pioglitazone—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000267	0.0041	CbGpPWpGaD
Pioglitazone—Hypertension—Prednisone—multiple sclerosis	0.000267	0.000899	CcSEcCtD
Pioglitazone—Headache—Mitoxantrone—multiple sclerosis	0.000265	0.000893	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000264	0.000889	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000264	0.000889	CcSEcCtD
Pioglitazone—Myalgia—Prednisone—multiple sclerosis	0.000263	0.000887	CcSEcCtD
Pioglitazone—Arthralgia—Prednisone—multiple sclerosis	0.000263	0.000887	CcSEcCtD
Pioglitazone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000263	0.000887	CcSEcCtD
Pioglitazone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000262	0.000885	CcSEcCtD
Pioglitazone—Insomnia—Betamethasone—multiple sclerosis	0.000262	0.000883	CcSEcCtD
Pioglitazone—Insomnia—Dexamethasone—multiple sclerosis	0.000262	0.000883	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000261	0.000881	CcSEcCtD
Pioglitazone—Discomfort—Prednisone—multiple sclerosis	0.00026	0.000876	CcSEcCtD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000259	0.00398	CbGpPWpGaD
Pioglitazone—Malnutrition—Methotrexate—multiple sclerosis	0.000258	0.000871	CcSEcCtD
Pioglitazone—Hypersensitivity—Prednisolone—multiple sclerosis	0.000256	0.000862	CcSEcCtD
Pioglitazone—Urticaria—Triamcinolone—multiple sclerosis	0.000253	0.000855	CcSEcCtD
Pioglitazone—Urticaria—Methylprednisolone—multiple sclerosis	0.000253	0.000853	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisone—multiple sclerosis	0.000252	0.00085	CcSEcCtD
Pioglitazone—Oedema—Prednisone—multiple sclerosis	0.000252	0.00085	CcSEcCtD
Pioglitazone—Infection—Prednisone—multiple sclerosis	0.00025	0.000845	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00025	0.000843	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00025	0.000843	CcSEcCtD
Pioglitazone—Back pain—Methotrexate—multiple sclerosis	0.00025	0.000842	CcSEcCtD
Pioglitazone—Fatigue—Betamethasone—multiple sclerosis	0.00025	0.000842	CcSEcCtD
Pioglitazone—Fatigue—Dexamethasone—multiple sclerosis	0.00025	0.000842	CcSEcCtD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000249	0.00382	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000248	0.00382	CbGpPWpGaD
Pioglitazone—Nervous system disorder—Prednisone—multiple sclerosis	0.000247	0.000834	CcSEcCtD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000247	0.00379	CbGpPWpGaD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000247	0.00379	CbGpPWpGaD
Pioglitazone—Skin disorder—Prednisone—multiple sclerosis	0.000245	0.000826	CcSEcCtD
Pioglitazone—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000244	0.00375	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000244	0.00375	CbGpPWpGaD
Pioglitazone—Hyperhidrosis—Prednisone—multiple sclerosis	0.000244	0.000822	CcSEcCtD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000243	0.00373	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000243	0.00373	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	0.000241	0.0037	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000241	0.0037	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000241	0.0037	CbGpPWpGaD
Pioglitazone—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000239	0.000808	CcSEcCtD
Pioglitazone—Anaemia—Methotrexate—multiple sclerosis	0.000239	0.000805	CcSEcCtD
Pioglitazone—Feeling abnormal—Betamethasone—multiple sclerosis	0.000238	0.000804	CcSEcCtD
Pioglitazone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000238	0.000804	CcSEcCtD
Pioglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000238	0.00365	CbGpPWpGaD
Pioglitazone—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000237	0.00364	CbGpPWpGaD
Pioglitazone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000235	0.000793	CcSEcCtD
Pioglitazone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000234	0.000791	CcSEcCtD
Pioglitazone—Malaise—Methotrexate—multiple sclerosis	0.000233	0.000785	CcSEcCtD
Pioglitazone—Vertigo—Methotrexate—multiple sclerosis	0.000232	0.000782	CcSEcCtD
Pioglitazone—Urticaria—Dexamethasone—multiple sclerosis	0.00023	0.000776	CcSEcCtD
Pioglitazone—Urticaria—Betamethasone—multiple sclerosis	0.00023	0.000776	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00023	0.000775	CcSEcCtD
Pioglitazone—Dizziness—Prednisolone—multiple sclerosis	0.000229	0.000774	CcSEcCtD
Pioglitazone—Asthenia—Triamcinolone—multiple sclerosis	0.000229	0.000772	CcSEcCtD
Pioglitazone—Asthenia—Methylprednisolone—multiple sclerosis	0.000228	0.00077	CcSEcCtD
Pioglitazone—Insomnia—Prednisone—multiple sclerosis	0.000228	0.000769	CcSEcCtD
Pioglitazone—Myalgia—Methotrexate—multiple sclerosis	0.00022	0.000741	CcSEcCtD
Pioglitazone—Arthralgia—Methotrexate—multiple sclerosis	0.00022	0.000741	CcSEcCtD
Pioglitazone—Chest pain—Methotrexate—multiple sclerosis	0.00022	0.000741	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000218	0.000736	CcSEcCtD
Pioglitazone—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000218	0.00335	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000218	0.00335	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000218	0.00335	CbGpPWpGaD
Pioglitazone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000218	0.000734	CcSEcCtD
Pioglitazone—Fatigue—Prednisone—multiple sclerosis	0.000217	0.000733	CcSEcCtD
Pioglitazone—Headache—Prednisolone—multiple sclerosis	0.000217	0.000733	CcSEcCtD
Pioglitazone—Discomfort—Methotrexate—multiple sclerosis	0.000217	0.000732	CcSEcCtD
Pioglitazone—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000215	0.00331	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000215	0.0033	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000215	0.0033	CbGpPWpGaD
Pioglitazone—Dizziness—Triamcinolone—multiple sclerosis	0.000211	0.000711	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000211	0.000711	CcSEcCtD
Pioglitazone—Dizziness—Methylprednisolone—multiple sclerosis	0.00021	0.00071	CcSEcCtD
Pioglitazone—Infection—Methotrexate—multiple sclerosis	0.000209	0.000706	CcSEcCtD
Pioglitazone—Feeling abnormal—Prednisone—multiple sclerosis	0.000208	0.000701	CcSEcCtD
Pioglitazone—Asthenia—Betamethasone—multiple sclerosis	0.000208	0.0007	CcSEcCtD
Pioglitazone—Asthenia—Dexamethasone—multiple sclerosis	0.000208	0.0007	CcSEcCtD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000207	0.00318	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000207	0.00318	CbGpPWpGaD
Pioglitazone—Nervous system disorder—Methotrexate—multiple sclerosis	0.000207	0.000697	CcSEcCtD
Pioglitazone—Skin disorder—Methotrexate—multiple sclerosis	0.000205	0.00069	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000204	0.000687	CcSEcCtD
Pioglitazone—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.0002	0.00308	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.0002	0.00308	CbGpPWpGaD
Pioglitazone—Urticaria—Prednisone—multiple sclerosis	0.0002	0.000675	CcSEcCtD
Pioglitazone—Headache—Triamcinolone—multiple sclerosis	0.0002	0.000674	CcSEcCtD
Pioglitazone—Headache—Methylprednisolone—multiple sclerosis	0.000199	0.000673	CcSEcCtD
Pioglitazone—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000199	0.00305	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000199	0.00305	CbGpPWpGaD
Pioglitazone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000198	0.000668	CcSEcCtD
Pioglitazone—Diarrhoea—Betamethasone—multiple sclerosis	0.000198	0.000668	CcSEcCtD
Pioglitazone—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000198	0.00304	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000198	0.00304	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000196	0.00301	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000196	0.00301	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—FAS—multiple sclerosis	0.000193	0.00296	CbGpPWpGaD
Pioglitazone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000192	0.000647	CcSEcCtD
Pioglitazone—Dizziness—Betamethasone—multiple sclerosis	0.000191	0.000646	CcSEcCtD
Pioglitazone—Dizziness—Dexamethasone—multiple sclerosis	0.000191	0.000646	CcSEcCtD
Pioglitazone—Insomnia—Methotrexate—multiple sclerosis	0.000191	0.000643	CcSEcCtD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000188	0.00289	CbGpPWpGaD
Pioglitazone—Dyspnoea—Methotrexate—multiple sclerosis	0.000188	0.000633	CcSEcCtD
Pioglitazone—Hypersensitivity—Prednisone—multiple sclerosis	0.000186	0.000626	CcSEcCtD
Pioglitazone—PPARG—Gene Expression—ZNF746—multiple sclerosis	0.000184	0.00283	CbGpPWpGaD
Pioglitazone—PPARG—Wnt Signaling Pathway Netpath—MYC—multiple sclerosis	0.000183	0.00281	CbGpPWpGaD
Pioglitazone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000182	0.000613	CcSEcCtD
Pioglitazone—Fatigue—Methotrexate—multiple sclerosis	0.000182	0.000613	CcSEcCtD
Pioglitazone—Headache—Dexamethasone—multiple sclerosis	0.000181	0.000612	CcSEcCtD
Pioglitazone—Headache—Betamethasone—multiple sclerosis	0.000181	0.000612	CcSEcCtD
Pioglitazone—Asthenia—Prednisone—multiple sclerosis	0.000181	0.00061	CcSEcCtD
Pioglitazone—PPARG—Wnt Signaling Pathway Netpath—MAPK1—multiple sclerosis	0.000179	0.00275	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	0.000176	0.0027	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000174	0.00267	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Methotrexate—multiple sclerosis	0.000174	0.000585	CcSEcCtD
Pioglitazone—Diarrhoea—Prednisone—multiple sclerosis	0.000172	0.000582	CcSEcCtD
Pioglitazone—PPARG—Gene Expression—PTBP1—multiple sclerosis	0.000168	0.00259	CbGpPWpGaD
Pioglitazone—Urticaria—Methotrexate—multiple sclerosis	0.000167	0.000564	CcSEcCtD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000167	0.00256	CbGpPWpGaD
Pioglitazone—Dizziness—Prednisone—multiple sclerosis	0.000167	0.000562	CcSEcCtD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000163	0.00251	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000163	0.00251	CbGpPWpGaD
Pioglitazone—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.00016	0.00246	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000159	0.00244	CbGpPWpGaD
Pioglitazone—Headache—Prednisone—multiple sclerosis	0.000158	0.000533	CcSEcCtD
Pioglitazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000157	0.00241	CbGpPWpGaD
Pioglitazone—Hypersensitivity—Methotrexate—multiple sclerosis	0.000155	0.000523	CcSEcCtD
Pioglitazone—PPARG—Signaling events mediated by HDAC Class I—STAT3—multiple sclerosis	0.000155	0.00238	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—SRM—multiple sclerosis	0.000153	0.00236	CbGpPWpGaD
Pioglitazone—Asthenia—Methotrexate—multiple sclerosis	0.000151	0.00051	CcSEcCtD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000149	0.00229	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000145	0.00223	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000145	0.00223	CbGpPWpGaD
Pioglitazone—Diarrhoea—Methotrexate—multiple sclerosis	0.000144	0.000486	CcSEcCtD
Pioglitazone—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000142	0.00218	CbGpPWpGaD
Pioglitazone—Dizziness—Methotrexate—multiple sclerosis	0.000139	0.00047	CcSEcCtD
Pioglitazone—PPARG—Circadian rythm related genes—FAS—multiple sclerosis	0.000136	0.00209	CbGpPWpGaD
Pioglitazone—PPARG—Signaling events mediated by HDAC Class I—TNF—multiple sclerosis	0.000134	0.00206	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—PRNP—multiple sclerosis	0.000133	0.00205	CbGpPWpGaD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.000133	0.00205	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000133	0.00204	CbGpPWpGaD
Pioglitazone—Headache—Methotrexate—multiple sclerosis	0.000132	0.000445	CcSEcCtD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000132	0.00202	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000131	0.00201	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000131	0.00201	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—SRM—multiple sclerosis	0.000131	0.00201	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000129	0.00199	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000129	0.00199	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—HNRNPA1—multiple sclerosis	0.000128	0.00196	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—U2AF2—multiple sclerosis	0.000128	0.00196	CbGpPWpGaD
Pioglitazone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000128	0.00196	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000126	0.00194	CbGpPWpGaD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	0.000124	0.00191	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000121	0.00186	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—PGR—multiple sclerosis	0.000115	0.00177	CbGpPWpGaD
Pioglitazone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000114	0.00175	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CYP24A1—multiple sclerosis	0.000108	0.00166	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CYP27B1—multiple sclerosis	0.000108	0.00166	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000108	0.00166	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000106	0.00162	CbGpPWpGaD
Pioglitazone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000105	0.00161	CbGpPWpGaD
Pioglitazone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000104	0.00159	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—PTPRC—multiple sclerosis	0.000104	0.00159	CbGpPWpGaD
Pioglitazone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000103	0.00159	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—SRM—multiple sclerosis	0.000103	0.00158	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—ZFP36L1—multiple sclerosis	0.000101	0.00155	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.0001	0.00154	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GPC5—multiple sclerosis	9.89e-05	0.00152	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—STAT3—multiple sclerosis	9.45e-05	0.00145	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.38e-05	0.00144	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.38e-05	0.00144	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	9.32e-05	0.00143	CbGpPWpGaD
Pioglitazone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.23e-05	0.00142	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP27B1—multiple sclerosis	9.23e-05	0.00142	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP24A1—multiple sclerosis	9.23e-05	0.00142	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—SRM—multiple sclerosis	9.17e-05	0.00141	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.02e-05	0.00139	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.84e-05	0.00136	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—TGFB1—multiple sclerosis	8.76e-05	0.00135	CbGpPWpGaD
Pioglitazone—PTGS1—Biological oxidations—POMC—multiple sclerosis	8.5e-05	0.00131	CbGpPWpGaD
Pioglitazone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.49e-05	0.0013	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GPC5—multiple sclerosis	8.44e-05	0.0013	CbGpPWpGaD
Pioglitazone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.41e-05	0.00129	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.37e-05	0.00129	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.37e-05	0.00129	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—RRM1—multiple sclerosis	8.2e-05	0.00126	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—TNF—multiple sclerosis	8.18e-05	0.00126	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—VDR—multiple sclerosis	8.06e-05	0.00124	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	7.83e-05	0.0012	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—PABPC1—multiple sclerosis	7.82e-05	0.0012	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.63e-05	0.00117	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.63e-05	0.00117	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	7.27e-05	0.00112	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	7.27e-05	0.00112	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.1e-05	0.00109	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—RPL5—multiple sclerosis	7.06e-05	0.00108	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—RRM1—multiple sclerosis	6.99e-05	0.00107	CbGpPWpGaD
Pioglitazone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.85e-05	0.00105	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GPC5—multiple sclerosis	6.65e-05	0.00102	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—IL6—multiple sclerosis	6.6e-05	0.00101	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP27B1—multiple sclerosis	6.46e-05	0.000993	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP24A1—multiple sclerosis	6.46e-05	0.000993	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.36e-05	0.000977	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.32e-05	0.00097	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	6.32e-05	0.00097	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.26e-05	0.000962	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SRM—multiple sclerosis	5.93e-05	0.00091	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GPC5—multiple sclerosis	5.91e-05	0.000908	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—PGR—multiple sclerosis	5.56e-05	0.000853	CbGpPWpGaD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.55e-05	0.000852	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—RRM1—multiple sclerosis	5.51e-05	0.000846	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	5.49e-05	0.000844	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.46e-05	0.000839	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.43e-05	0.000833	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SRM—multiple sclerosis	5.29e-05	0.000813	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.98e-05	0.000765	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.9e-05	0.000753	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—RRM1—multiple sclerosis	4.9e-05	0.000753	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SRM—multiple sclerosis	4.87e-05	0.000747	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SRM—multiple sclerosis	4.82e-05	0.000741	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.74e-05	0.000727	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—BCHE—multiple sclerosis	4.71e-05	0.000723	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.66e-05	0.000716	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—IL6—multiple sclerosis	4.66e-05	0.000715	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TYK2—multiple sclerosis	4.64e-05	0.000712	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	4.51e-05	0.000693	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.47e-05	0.000687	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.27e-05	0.000656	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.25e-05	0.000653	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4.18e-05	0.000641	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4.18e-05	0.000641	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.08e-05	0.000627	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—BCHE—multiple sclerosis	4.02e-05	0.000617	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—VDR—multiple sclerosis	3.88e-05	0.000596	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GPC5—multiple sclerosis	3.82e-05	0.000587	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.8e-05	0.000584	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.73e-05	0.000572	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.73e-05	0.000572	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.67e-05	0.000564	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MMP9—multiple sclerosis	3.65e-05	0.000561	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.64e-05	0.00056	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.43e-05	0.000527	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.43e-05	0.000527	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.41e-05	0.000524	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.4e-05	0.000522	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.4e-05	0.000522	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.35e-05	0.000514	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.32e-05	0.00051	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.27e-05	0.000502	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—STAT3—multiple sclerosis	3.25e-05	0.000499	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—MYC—multiple sclerosis	3.21e-05	0.000492	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.18e-05	0.000489	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SRM—multiple sclerosis	3.18e-05	0.000489	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.16e-05	0.000486	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—BCHE—multiple sclerosis	3.16e-05	0.000486	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.14e-05	0.000482	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GPC5—multiple sclerosis	3.11e-05	0.000477	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TGFB1—multiple sclerosis	3.01e-05	0.000462	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.98e-05	0.000457	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MAPK1—multiple sclerosis	2.95e-05	0.000453	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.95e-05	0.000453	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—APOE—multiple sclerosis	2.83e-05	0.000435	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.82e-05	0.000434	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—BCHE—multiple sclerosis	2.81e-05	0.000432	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TNF—multiple sclerosis	2.81e-05	0.000432	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.6e-05	0.000399	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.58e-05	0.000396	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.46e-05	0.000377	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—POMC—multiple sclerosis	2.43e-05	0.000374	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—APOE—multiple sclerosis	2.42e-05	0.000371	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—IL6—multiple sclerosis	2.27e-05	0.000348	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.24e-05	0.000344	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.24e-05	0.000344	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ALB—multiple sclerosis	2.22e-05	0.000341	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.19e-05	0.000337	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.11e-05	0.000324	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—POMC—multiple sclerosis	2.08e-05	0.000319	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.05e-05	0.000315	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2e-05	0.000307	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.92e-05	0.000295	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—APOE—multiple sclerosis	1.9e-05	0.000292	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ALB—multiple sclerosis	1.89e-05	0.000291	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.88e-05	0.000289	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.82e-05	0.000279	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.72e-05	0.000264	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.72e-05	0.000264	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.7e-05	0.000261	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—APOE—multiple sclerosis	1.69e-05	0.00026	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—POMC—multiple sclerosis	1.63e-05	0.000251	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.62e-05	0.000249	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.56e-05	0.00024	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MYC—multiple sclerosis	1.54e-05	0.000237	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.49e-05	0.000229	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—multiple sclerosis	1.49e-05	0.000229	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.48e-05	0.000227	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—POMC—multiple sclerosis	1.45e-05	0.000223	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—multiple sclerosis	1.33e-05	0.000204	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—APOE—multiple sclerosis	1.09e-05	0.000168	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—APOE—multiple sclerosis	9.76e-06	0.00015	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—BCHE—multiple sclerosis	9.76e-06	0.00015	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—POMC—multiple sclerosis	9.39e-06	0.000144	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—APOE—multiple sclerosis	8.98e-06	0.000138	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—APOE—multiple sclerosis	8.9e-06	0.000137	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—multiple sclerosis	8.56e-06	0.000132	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—POMC—multiple sclerosis	8.38e-06	0.000129	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—POMC—multiple sclerosis	7.71e-06	0.000118	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—POMC—multiple sclerosis	7.64e-06	0.000117	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—multiple sclerosis	7.64e-06	0.000117	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—multiple sclerosis	7.03e-06	0.000108	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—multiple sclerosis	6.97e-06	0.000107	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—APOE—multiple sclerosis	5.87e-06	9.01e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—POMC—multiple sclerosis	5.04e-06	7.74e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—multiple sclerosis	4.6e-06	7.06e-05	CbGpPWpGaD
